{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:09:00Z","timestamp":1767478140028,"version":"3.48.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04128-y","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:54:14Z","timestamp":1764215654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of tumor-infiltrating lymphocytes combined with tumor-stromal ratio for axillarylymph node metastasis in breast cancer patients - a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Huan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoxia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"4128_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4128_CR2","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1245\/s10434-024-15370-1","volume":"31","author":"JJ Jung","year":"2024","unstructured":"Jung JJ, Cheun JH, Kang E, et al. Survival after contralateral axillary metastasis in breast cancer. Ann Surg Oncol. 2024;31(8):5189\u201396.","journal-title":"Ann Surg Oncol"},{"key":"4128_CR3","doi-asserted-by":"publisher","first-page":"1482020","DOI":"10.3389\/fimmu.2024.1482020","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, Sun S, Deng X, et al. Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model. Front Immunol. 2024;15:1482020.","journal-title":"Front Immunol"},{"issue":"5","key":"4128_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jop.13359","volume":"52","author":"GVD Silva","year":"2023","unstructured":"Silva GVD, da Silva Dolens E, Paranaiba LMR, et al. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis. J Oral Pathol Med. 2023;52(5):402\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"4128_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ygyno.2019.12.022","volume":"156","author":"L Zong","year":"2020","unstructured":"Zong L, Zhang Q, Kong Y, et al. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery. Gynecol Oncol. 2020;156(3):676\u201381.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"4128_CR6","doi-asserted-by":"publisher","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open. 2020;3(12):e2028086.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"4128_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/radiol.2020192534","volume":"295","author":"JM Chang","year":"2020","unstructured":"Chang JM, Leung JWT, Moy L, et al. Axillary nodal evaluation in breast cancer: state of the art. Radiology. 2020;295(3):500\u201315.","journal-title":"Radiology"},{"issue":"4","key":"4128_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","volume":"473","author":"GW van Pelt","year":"2018","unstructured":"van Pelt GW, Kjaer-Frifeldt S, van Krieken J, et al. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Arch. 2018;473(4):405\u201312.","journal-title":"Virchows Arch"},{"issue":"2","key":"4128_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259\u201371.","journal-title":"Ann Oncol"},{"issue":"4","key":"4128_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00595-020-02157-6","volume":"51","author":"T Yokotani","year":"2021","unstructured":"Yokotani T, Ikeda N, Hirao T, et al. Predictive value of tumor-infiltrating lymphocytes for pathological response to neoadjuvant chemotherapy in breast cancer patients with axillary lymph node metastasis. Surg Today. 2021;51(4):595\u2013604.","journal-title":"Surg Today"},{"issue":"8","key":"4128_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/jamaoncol.2024.1917","volume":"10","author":"VCM Geurts","year":"2024","unstructured":"Geurts VCM, Balduzzi S, Steenbruggen TG, et al. Tumor-infiltrating lymphocytes in patients with stage I triple-negative breast cancer untreated with chemotherapy. JAMA Oncol. 2024;10(8):1077\u201386.","journal-title":"JAMA Oncol"},{"issue":"13","key":"4128_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/jama.2024.3056","volume":"331","author":"RA Leon-Ferre","year":"2024","unstructured":"Leon-Ferre RA, Jonas SF, Salgado R, et al. Tumor-infiltrating lymphocytes in triple-negative breast cancer. JAMA. 2024;331(13):1135\u201344.","journal-title":"JAMA"},{"issue":"7","key":"4128_CR13","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.4103\/jcrt.jcrt_41_24","volume":"20","author":"Y Shi","year":"2024","unstructured":"Shi Y, Guo Z, Wang Q, et al. Prognostic value of tumor-infiltrating lymphocyte subtypes and microorganisms in triple-negative breast cancer. J Cancer Res Ther. 2024;20(7):1983\u201390.","journal-title":"J Cancer Res Ther"},{"key":"4128_CR14","doi-asserted-by":"crossref","unstructured":"Hayee A, Kobayashi E, Motozono C et al. Characterization of Tumor-Infiltrating Lymphocyte-Derived atypical TCRs recognizing breast cancer in an MR1-Dependent manner. Cells. 2024;13(20):1711.","DOI":"10.3390\/cells13201711"},{"issue":"1","key":"4128_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-024-07334-6","volume":"207","author":"K Chin","year":"2024","unstructured":"Chin K, Landen AH, Kovacs A, et al. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast Cancer Res Treat. 2024;207(1):49\u201363.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4128_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02811-w","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Anwar M, Wang X, et al. Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer. Discov Oncol. 2025;16(1):977.","journal-title":"Discov Oncol"},{"issue":"2","key":"4128_CR17","doi-asserted-by":"publisher","first-page":"e20241225","DOI":"10.1590\/1806-9282.20241225","volume":"71","author":"O Okcu","year":"2025","unstructured":"Okcu O, Ozturk C, Yalcin AC, et al. Tumor-stroma type and tumor-stroma ratio predict neoadjuvant chemotherapy response in breast cancer. Rev Assoc Med Bras (1992). 2025;71(2):e20241225.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"8","key":"4128_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/ijc.32857","volume":"146","author":"KMH Vangangelt","year":"2020","unstructured":"Vangangelt KMH, Green AR, Heemskerk IMF, et al. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer. Int J Cancer. 2020;146(8):2296\u2013304.","journal-title":"Int J Cancer"},{"issue":"3","key":"4128_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-022-06587-3","volume":"193","author":"SC Hagenaars","year":"2022","unstructured":"Hagenaars SC, Vangangelt KMH, Van Pelt GW, et al. Standardization of the tumor-stroma ratio scoring method for breast cancer research. Breast Cancer Res Treat. 2022;193(3):545\u201353.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4128_CR20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1186\/s12885-022-10183-5","volume":"22","author":"D Yan","year":"2022","unstructured":"Yan D, Ju X, Luo B, et al. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer. BMC Cancer. 2022;22(1):1082.","journal-title":"BMC Cancer"},{"issue":"4","key":"4128_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/ol.2025.14926","volume":"29","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang B, Wang X, et al. Prognostic value of preoperative modified Glasgow prognostic score in predicting overall survival in breast cancer patients: a retrospective cohort study. Oncol Lett. 2025;29(4):180.","journal-title":"Oncol Lett"},{"issue":"1","key":"4128_CR22","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.1038\/s41598-025-96592-5","volume":"15","author":"K Li","year":"2025","unstructured":"Li K, Chen Y, Zhang Z, et al. Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage I-III colorectal cancer. Sci Rep. 2025;15(1):11517.","journal-title":"Sci Rep"},{"issue":"4","key":"4128_CR23","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.14943","volume":"29","author":"K Li","year":"2025","unstructured":"Li K, Zeng X, Zhang Z, et al. Pan\u2011immune\u2011inflammatory values predict survival in patients after radical surgery for non\u2011metastatic colorectal cancer: a retrospective study. Oncol Lett. 2025;29(4):197.","journal-title":"Oncol Lett"},{"issue":"12","key":"4128_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jamasurg.2024.3944","volume":"159","author":"I Skarping","year":"2024","unstructured":"Skarping I, Bendahl PO, Szulkin R, et al. Prediction of high nodal burden in patients with sentinel node-positive luminal ERBB2-negative breast cancer. JAMA Surg. 2024;159(12):1393\u2013403.","journal-title":"JAMA Surg"},{"key":"4128_CR25","first-page":"755","volume":"17","author":"X Aimaiti","year":"2025","unstructured":"Aimaiti X, Wang Y, Ismtula D, et al. Bystin is a prognosis and immune biomarker: from Pan-Cancer analysis to validation in breast cancer. Breast Cancer (Dove Med Press). 2025;17:755\u201379.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"2","key":"4128_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.21037\/tcr-24-1291","volume":"14","author":"Y Jing","year":"2025","unstructured":"Jing Y, Wang Y, Li Y, et al. Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer. Transl Cancer Res. 2025;14(2):881\u2013906.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4128_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01990-w","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, Wang Y, Wang J, et al. Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer. Discov Oncol. 2025;16(1):218.","journal-title":"Discov Oncol"},{"issue":"8","key":"4128_CR28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.21037\/gs-2025-7","volume":"14","author":"S Duan","year":"2025","unstructured":"Duan S, Aisimutula D, Wang Y, et al. Factors influencing the efficacy of neoadjuvant chemotherapy for HER-2-low early-stage breast cancer and a predictive model for pathological complete response. Gland Surg. 2025;14(8):1418\u201332.","journal-title":"Gland Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04128-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:05:11Z","timestamp":1767477911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04128-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4128"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04128-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in accordance with the Declaration of Helsinki. The study was approved by the Shanghai Changhai Hospital Medical Ethics Committee (No.CHEC2025-213). The principle of informed consent was followed throughout the experiment, and information about the study was provided to patients or their families, and consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}